Banque Pictet & Cie Sa Astrazeneca PLC Transaction History

Banque Pictet & Cie Sa

$13.1 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 27, 2023	SELL	$64.85 - $71.7 $5.14 Million - $5.69 Million	-79,319 Reduced 98.44%	1,253 $84,000
Q3 2023 Nov 02, 2023	SELL	$64.85 - $71.7 $4.2 Million - $4.64 Million	-64,699 Reduced 44.54%	80,572 $5.46 Million
Q2 2023 Aug 04, 2023	SELL	$69.91 - $75.81 $458,329 - $497,010	-6,556 Reduced 4.32%	145,271 $10.4 Million
Q1 2023 May 01, 2023	SELL	$63.15 - $71.6 $1.92 Million - $2.18 Million	-30,461 Reduced 16.71%	151,827 $10.5 Million
Q4 2022 Feb 06, 2023	SELL	$54.21 - $70.44 $340,980 - $443,067	-6,290 Reduced 3.34%	182,288 $0
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $69,191 - $177,153	-1,305 Reduced 0.69%	188,578 $10.3 Billion
Q2 2022 Aug 08, 2022	SELL	$59.26 - $71.14 $506,910 - $608,531	-8,554 Reduced 4.31%	189,883 $12.5 Million
Q1 2022 May 04, 2022	SELL	$55.72 - $67.12 $96,451 - $116,184	-1,731 Reduced 0.86%	198,437 $13.2 Million
Q4 2021 Feb 02, 2022	SELL	$54.02 - $63.83 $183,127 - $216,383	-3,390 Reduced 1.67%	200,168 $11.7 Million
Q3 2021 Nov 10, 2021	SELL	$55.56 - $60.79 $1.76 Million - $1.92 Million	-31,631 Reduced 13.45%	203,558 $24.6 Million
Q2 2021 Aug 12, 2021	BUY	$48.42 - $60.18 $132,767 - $165,013	2,742 Added 1.18%	235,189 $28.2 Million
Q1 2021 May 11, 2021	BUY	$47.16 - $54.44 $231,508 - $267,245	4,909 Added 2.16%	232,447 $23.2 Million
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $127,510 - $152,476	2,628 Added 1.17%	227,538 $22.8 Million
Q3 2020 Nov 10, 2020	SELL	$53.07 - $61.1 $215,358 - $247,943	-4,058 Reduced 1.77%	224,910 $24.6 Million
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $117,361 - $150,609	-2,723 Reduced 1.18%	228,968 $23.8 Million
Q1 2020 Apr 30, 2020	SELL	$37.79 - $51.33 $71,007 - $96,449	-1,879 Reduced 0.8%	231,691 $20.7 Million
Q4 2019 Feb 03, 2020	BUY	$42.46 - $50.46 $57,660 - $68,524	1,358 Added 0.58%	233,570 $23.5 Million
Q3 2019 Nov 08, 2019	BUY	$40.12 - $45.47 $642,963 - $728,702	16,026 Added 7.41%	232,212 $20.8 Million
Q2 2019 Aug 07, 2019	SELL	$37.28 - $41.68 $949,409 - $1.06 Million	-25,467 Reduced 10.54%	216,186 $17.7 Million
Q1 2019 May 02, 2019	SELL	$35.49 - $43.02 $1.22 Million - $1.48 Million	-34,315 Reduced 12.43%	241,653 $19.3 Million
Q4 2018 Jan 31, 2019	SELL	$36.86 - $41.49 $150,462 - $169,362	-4,082 Reduced 1.46%	275,968 $20.6 Million
Q3 2018 Nov 07, 2018	BUY	$34.76 - $39.72 $101,846 - $116,379	2,930 Added 1.06%	280,050 $21.8 Million
Q2 2018 Aug 09, 2018	SELL	$34.55 - $37.05 $88,586 - $94,996	-2,564 Reduced 0.92%	277,120 $19.2 Million
Q1 2018 May 09, 2018	BUY	$32.97 - $36.63 $451,853 - $502,014	13,705 Added 5.15%	279,684 $19.2 Million
Q4 2017 Feb 09, 2018	SELL	$32.09 - $34.78 $61,612 - $66,777	-1,920 Reduced 0.72%	265,979 $18.4 Million
Q3 2017 Nov 07, 2017	SELL	$28.96 - $34.0 $44,830 - $52,632	-1,548 Reduced 0.57%	267,899 $17.8 Million
Q2 2017 Aug 09, 2017	BUY	N/A	269,447	269,447 $18 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.

Account